Internal Medicine, Rheumatology · New York, NY
NPI
1679619233
Since 2007
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1st Ave & E 16th St, 7th Floor
New York, NY, 10003
Phone (212) 420-3131
Groups this clinician bills Medicare through
Medicare paid, 2024
$50K
666 services
Medicare patients, 2024
161
Average age 74
Drug cost, 2024
$6.2M
22,238 prescriptions
Company payments, 2025
$1,077
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Eddys Disla was code 99214 (office e&m - established), 263 times for 111 patients. In total Eddys Disla billed 666 services in 10 codes, and Medicare paid $50K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-04-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 263 | 111 | $75.98 | $20K |
| 99215 Office E&M - Established | Office | 243 | 108 | $111.28 | $27K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 143 | 106 | $14.04 | $2,008 |
By year: 2022 $53K for 612 services; 2023 $52K for 561 services; 2024 $50K for 666 services.
Medicare prescription drug claims, 2024
In 2024, the drug Eddys Disla prescribed most often to Medicare patients was Vitamin D2 (Ergocalciferol (Vitamin D2)), with 1,226 prescriptions and refills. In total Eddys Disla wrote 22,238 Medicare prescriptions that cost $6.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Vitamin D2 Ergocalciferol (Vitamin D2) | 1,226 | 1,444 | 238 | $2,563 |
| Sulfasalazine Generic | 1,169 | 1,361 | 222 | $8,803 |
| Hydroxychloroquine Sulfate Generic | 1,041 | 1,347 | 166 | $12K |
| Montelukast Sodium Generic | 905 | 1,085 | 155 | $5,089 |
| Methotrexate Methotrexate Sodium | 892 | 1,072 | 144 | $14K |
| Gabapentin Generic | 846 | 1,178 | 198 | $4,784 |
| Folic Acid Generic | 500 | 684 | 92 | $675 |
| Alendronate Sodium Generic | 486 | 552 | 80 | $1,764 |
| Atorvastatin Calcium Generic | 475 | 1,022 | 122 | $4,473 |
| Omeprazole Generic | 459 | 594 | 96 | $2,368 |
| Amlodipine Besylate Generic | 440 | 776 | 112 | $1,695 |
| Ammonium Lactate Generic | 432 | 440 | 66 | $6,227 |
| Levothyroxine Sodium Generic | 405 | 752 | 87 | $4,794 |
| Carvedilol Generic | 401 | 713 | 81 | $1,639 |
| Rosuvastatin Calcium Generic | 366 | 827 | 111 | $4,802 |
Brand drugs: 3,866 claims; generic drugs: 18,191 claims; opioid claims: 19.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Eddys Disla $1,077 ($1,077 in general payments such as food, travel and fees) from 7 companies. The largest payer was Novartis Pharmaceuticals Corporation with $262.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.